We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Travel + Leisure Co
TNL
$4.54B
| $25.1M | 0.52% |
+648,140
| New | +$23.4M |
|
52
CBRE Group
CBRE
$40.8B
| $24.9M | 0.52% |
+726,976
| New | +$23.3M |
|
53
Nike
NKE
$61.9B
| $24.9M | 0.52% |
+517,342
| New | +$24.3M |
|
54
F5
FFIV
$22.1B
| $24M | 0.5% |
+183,822
| New | +$22.9M |
|
55
Vertex Pharmaceuticals
VRTX
$121B
| $23.9M | 0.5% |
+201,522
| New | +$22.7M |
|
56
VF Corp
VFC
$6.68B
| $23.7M | 0.5% |
+335,887
| New | +$22.2M |
|
57
Electronic Arts
EA
$52.4B
| $23.3M | 0.49% |
+495,180
| New | +$20.4M |
|
58
Edwards Lifesciences
EW
$47.6B
| $23.2M | 0.49% |
+1,094,388
| New | +$22M |
|
59
Bristol-Myers Squibb
BMY
$127B
| $22.7M | 0.47% |
+384,227
| New | +$21.7M |
|
60
Oracle
ORCL
$331B
| $22.2M | 0.46% |
+493,327
| New | +$20.1M |
|
61
Wells Fargo
WFC
$261B
| $21.9M | 0.46% |
+398,728
| New | +$21.1M |
|
62
American International
AIG
$41.9B
| $21.3M | 0.45% |
+380,288
| New | +$20.4M |
|
63
Citigroup
C
$222B
| $21.2M | 0.44% |
+391,619
| New | +$20.8M |
|
64
RTX Corp
RTX
$287B
| $21M | 0.44% |
+289,594
| New | +$19.7M |
|
65
ConocoPhillips
COP
$147B
| $20.6M | 0.43% |
+297,752
| New | +$20.8M |
|
|
RHT
66
DELISTED
Red Hat Inc
RHT
| $20.3M | 0.42% |
+293,006
| New | +$17.7M |
|
67
Boston Scientific
BSX
$65.8B
| $20.3M | 0.42% |
+1,528,825
| New | +$19.5M |
|
68
Starbucks
SBUX
$118B
| $19.9M | 0.42% |
+484,346
| New | +$18.9M |
|
69
Assurant
AIZ
$13.7B
| $19.8M | 0.41% |
+289,646
| New | +$19.3M |
|
70
Rockwell Automation
ROK
$51.4B
| $19.7M | 0.41% |
+177,409
| New | +$19.5M |
|
71
Caterpillar
CAT
$409B
| $19.6M | 0.41% |
+214,039
| New | +$20.8M |
|
|
DISCK
72
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $19.5M | 0.41% |
+577,418
| New | +$19.7M |
|
73
Elevance Health
ELV
$81.9B
| $19.4M | 0.41% |
+154,450
| New | +$19.1M |
|
|
AMJ
74
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $19.2M | 0.4% |
+417,000
| New | +$20.4M |
|
75
Ameriprise Financial
AMP
$46.8B
| $19M | 0.4% |
+143,560
| New | +$18.2M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.